A preliminary experimental in vivo study of the effect of photodynamic therapy on human pituitary adenoma implanted in mice

British Journal of Neurosurgery

Volumn 12, Issue 2, 1998, Pages 140-145

  Kirollos, R W ^a,b   Marks, P V ^a   Igbaseimokumo, U ^a   Chakrabarty, A ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b WALTON CENTRE FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

Adjuvant therapy; Photodynamic therapy; Pituitary adenoma

Indexed keywords

HEMATOPORPHYRIN DERIVATIVE; PHOTOSENSITIZING AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLEEDING; CELL DEATH; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; HYPOPHYSIS ADENOMA; INFLAMMATION; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL;

ADENOMA; ANIMALS; CELL SURVIVAL; HEMATOPORPHYRIN PHOTORADIATION; HUMANS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; PITUITARY GLAND; PITUITARY NEOPLASMS; RATS;

EID: 0031943364     PISSN: 02688697     EISSN: None     Source Type: Journal    
DOI: 10.1080/02688699845285     Document Type: Article

References (44)

1. Laws ER, Piepgras DG, Randall RV, Abboud CF. Neurosurgical management of acromegaly. Results in 82 patients treated between 1972 and 1977. J Neurosurg 1979;50:454-61.
2. Grisoli F, Leclercq T, Jaquet P, Guibout M, Winteler J-P, Hassoun J, et al. Transsphenoidal surgery for acromegaly - long-term results in 100 patients. Surg Neurol 1985;23:513-19.
3. Tucker G, Grubb SR, Wigand JP, Watlington O, Blackard WG, Becker DP The treatment of acromegaly by transsphenoidal surgery. Arch Intern Med 1980;140:795-802.
4. Randall RV, Laws ER, Abboud CF, Ebersold MJ, Kao PC, Scheithauer BW Transsphenoidal microsurgical treatment of prolactin-producing pituitary denomas. Results in 100 patients. Mayo Clin Proc 1983;58:108-21.
5. Post KD, Biller BJ, Adelman LS, Molitch ME, Wolpert SM, Reichlin S. Selective transsphenoidal adenomectomy in women with galactorrhea-amenorrhea. JAMA 1979;242:158-162.
6. Wilson CB. Adecade of pituitary microsurgery. The Herbert Olivecrona lecture. J Neurosurg 1984;61:814-33.
7. Ebersold MJ, Quast LM, Laws ER, Scheithauer B, Randall RV. Long-term results in 114 patients in transsphenoidal removal of nonfunctioning pituitary adenomas. J Neurosurg 1986;64:713-719.
8. Feek CM, McLelland J, Seth J, Toft AD, Irvine WJ, Padfield PL, et al. How effective is external pituitary irradiation for growth hormone-secreting pituitary tumours? Clin Endocrinol 1984;20:401-408.
9. Clarke SD, Woo SY, Butler EB, Dennis WS, Lu H, Carpenter LS, et al. Treatment of secretory pituitary adenoma with radiation therapy. Radiology 1993;188:759-63.
10. Brada M, Ford D, Ashley S, Bliss JM, Crowley S, Mason M, et al. Risk of second brain tumour after conservative surgery and radiotherapy for pituitary adenoma. BMJ 1992;304:1343-6.
11. Al-Mefty O, Kersh JE, Routh A, Smith RR. The long-term effects of radiation therapy for benign brain tumours in adults. J Neurosurg 1990;73:502-12.
12. van Schaardenburg D, Roelfsema F, van Seters AP, Vielvoye GJ. Bromocriptine therapy for non-functioning pituitary adenoma. Clin Endocrinol 1989;30:475-84.
13. Haase R, Jaspers C, Schulte HM, Lancranjan I, Pfingsten H, Orri-Fend M, et al. Control of prolactin-secreting macroadenomas with parental, long-acting bromocriptine in 30 patients treated for up to 3 years. Clin Endocrinol 1993;38:165-76.
14. Plockinger U, Reichel M, Fett U, Saeger W, Quabbe HJ. Preoperative Octreotide treatment of growth hormone-secreting and clinically nonfunctioning pituitary macroadenomas: effect on tumor volume and lack of carrelation with immunohistochemistry and Somatostatin receptor scintigraphy. J Clin Endocrinol Metab 1994;79:1416-1423.
15. Barkan AL, Lloyd RV, Chandler WF, Hatfield MK, Gebraski SS, Kelch RP, et al. Preoperative treatment of acromegaly with long-acting Somatostain analog SMS 201-995: shrinkage of invasive pituitary macroadenomas and improved surgical remission rate. J Clin Endocrinol Metab 1988;67:1040-8.
16. Boggan JE, Bolger C, Edwards MSB. Effect of hematoporphyrin derivative photoradiation therapy on surgical in the at 9L gliosarcoma brain tumour model. J Neurosurg 1985;63:113-118.
17. Gomer CJ. Photodynamic therapy in the treatment of malignancies. Semin Hematol 1989;26:27-34.
18. Dougherty TJ, Marcus SL. Photodynamic therapy. Eur J Cancer 1992;28A:1734-42.
19. Henderson BW, Dougherty TJ. How does photodynamic therapy work? Photochem Photobiol 1992;55:145-57.
20. Marks PV, Buxton T, Furneaux CE. In vitro study of the effect of photodynamic therapy on pituitary adenomas. Br J Neurosurg 1993;7:401-6.
21. Laws ER, Cortese DA, Kinsey JH, Eagan RT, Anderson RE. Photoradiation therapy in the treatment of malignant brain tumors: a Phase I (feasibility) study. Neurosurgery 1981;9:672-8.
22. Perria C, Carai M, Falzoi A, Orunesu G, Rocca A, Massarelli G, et al. Photodynamic therapy of malignant brain tumors: clinical results of, difficulties with, questions about, and future prospects for the neurosurgical applications. Neurosurgery 1988;23:557-63.
23. Muller PJ, Wilson BC. Photodynamic therapy of malignant primary brain tumours: clinical effects, post-operative ICP, and light penetration of the brain. Photochem Photobiol 1987;46:929-935.
24. Kaye AH, Morstyn G, Brownbill D. Adjuvant high-dose photoradiation therapy in the treatment of cerebral glioma: a Phase I/II study. J Neurosurg 1987;67:500-505.
25. Wieman TJ, Mang TS, Fingar VH, Hill TG, Reed WR, Corey TS, et al. Effect oh photodynamic therapy on blood flow in normal and tumor vessels. Surgery 1988;104:512-17.
26. He DP, Hampton JA, Keck R, Selman SH. Photodynamic therapy: effect on the endothelial cell of the rat aorta. Photochem Photobiol 1991;54:801-4.
27. Nelson JS, Wright WH, Berns MW. Histopathological comparison of the effects of hematoporphyrin derivative on two different murine tumors using computer-enhanced digital video fluorescence microscopy. Cancer Res 1985;45:5781-6.
28. Pass HI. Photodynamic therapy in oncology: mechanisms and clinical use. J Nat Cancer Inst 1993;85:443-56.
29. Fingar VH, Henderson BW. Drug and light dose dependence of photodynamic therapy: a study of tumor and normal tissue response. Photoch Photobiol 1987;46:837-41.
30. Oritigano TC, Karesh SM, Henkin RE, Halama JR, Reichman OH. Photodynamic therapy for intracranial neoplasms: investigations of photosesitizer uptake and distribution using Indium-111 Photofrin-II single photon emission computed tomography scans in humans with intracranial neoplasms. Neurosurgery 1993;32:357-64.
31. Wan S, Parrish JA, Anderson RR, Madden M Transmittance of nonionizing radiation in human tissues. Photochem Photobiol 1981;34:679-81.
32. Wilson BC, Muller PJ, Yanch JC Instrumentation and light dosimetry for intra-operative photodynamic therapy (PDT) of malignant brain tumours. Phys Med Biol 1986;31(2):125-33.
33. Wise BL, Taxdal DR. Studies of the blood-brain barrier utilizing hematoporphyrin. Brain Res 1967;4:387-9.
34. Pantelouris EM. Absence of thymus in a mouse mutant. Nature 1968;217:370-1.
35. Rana MW, Pinkerton H, Thornton H, Nagy D Heterotransplantation of human glioblastoma multiforme and meningioma to nude mice. Proc Soc Exp Biol Med 1977;155:85-8.
36. Shapiro WR, Basler GA, Chernik NL Human brain tumour transplantation into nude mice. J Nat Cancer Inst 1979;62:447-53.
37. Braley NJ, Bloom HJG, Davies AJS, Swift SM. Growth of human gliomas in immune-deficient mice: a possible model for pre-clinical therapy studies. Br J Cancer 1978;38:263-72.
38. Jones TR, Bigner SH, Schold SC, Eng LF, Bigner DD. Anaplastic human gliomas grown in athymic mice. Morphology and glial fibrillary acidic protein expression. Am J Pathol 1981;105:316-27.
39. Kaye AH, Morstyn G, Ashcroft RG. Uptake and retension of hematoporphyrinderivative in an in vivo/ in vitro model of cerebral glioma. Neurosurgery 1985;17:883-90.
40. Gilson D, Dixon B, Ash DV, Vernon D and Brown SB. The response of a rodent fibrosarcoma to superficial/interstitial photochemotherapy, chemotherapy or radiotherapy. Radiother Oncol 1990;18:271-9.
41. 14H] hematoporphyrin derivative distribution in malignant and normal tissue. Cancer Res 1979;39:146-51.
42. Svaasand LO. Photodynamic and photohyperthermic response of malignant tumors. Med Phys 1985;12:455-61.
43. Christensen T, Wahl A, Smedshammer L. Effects of haematoporphyrin derivative and light in combination with hyperthermia on cells in culture. Br J Cancer 1984;50:85-9.
44. Fingar VH, Wieman TJ, Wiehle SA, Cerrto PB. The role of microvascular damage in photodynamic therapy: the effect of treatment on vessel constriction, permeability, and leukocyte adhesion. Cancer Res 1992;52:4914-21.